Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07498322 · ClinicalTrials.gov registry record · NA
Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System
A NA study, sponsored by University of Illinois at Chicago.
- Not yet
- Registry status
- NA
- Development phase
- 271,031
- Enrollment target
NCT07498322: Clinical Trial NA study, sponsored by University of Illinois at Chicago.
NCT07498322 is a NA study that has not yet begun recruiting, run by University of Illinois at Chicago. The registered enrollment target is 271,031 participants, above the 1,399-participant average among 58,714 other NA trials with a reported enrollment target (19273% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07498322, a NA study, has not yet begun recruiting, sponsored by University of Illinois at Chicago.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 271,031 participants
- Enrollment target
Study Summary
This study, called the Chicago Data-driven Opioid use disorder Screening, Engagement, Treatment and Planning (C-DOSETaP) System, tests a new system of clinical care for patients with opioid use disorder (OUD) across a large health system. The main questions this study aims to answer are: 1. Does the C-DOSETaP System increase screening for patients with OUD; 2. Does the C-DOSETaP System improve continuity of health care for patients with OUD; 3. Does the C-DOSETaP System increase use of medications for opioid use disorder; and 4. Does the C-DOSETaP System reduce the number of opioid-related deaths in the neighborhoods served.
Primary Outcome
Aggregate rate of data-driven OUD screening across the health system
Interventions
- OTHER OUD screening
- OTHER MOUD
- OTHER Continuity of care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 271,031 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2029-06-30 |
| Phase | NA |
What is known before NCT07498322 opens enrollment
NCT07498322 is an interventional study that assigns participants to a tested intervention. Its 271,031 participants enrollment target places it among the larger protocols in the corpus, above the 1,399-participant average among 58,714 other NA trials with a reported enrollment target (19273% higher).
The record links to 0 conditions, and to 3 interventions - of which OUD screening is the first listed.
NCT07498322 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07498322 about?
NCT07498322 is a clinical study titled "Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System". This study, called the Chicago Data-driven Opioid use disorder Screening, Engagement, Treatment and Planning (C-DOSETaP) System, tests a new system of clinical care for patients with opioid use disorder (OUD) across a large health system. The main questions this study aims to answer are: 1. Does t...
What is the current status of trial NCT07498322?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 271,031 participants. The study started on 2026-06-01. Estimated completion is 2029-06-30.
What interventions are being tested in trial NCT07498322?
The interventions under investigation include: OUD screening (OTHER), MOUD (OTHER), Continuity of care (OTHER).
Who is sponsoring clinical trial NCT07498322?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07498322's enrollment target sits among peer trials
271,031 1st of 2000 higher than 2,000 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04735835 · 250,000 participants · NA
Personalized Responses to Dietary Composition Trial 3
- NCT02280733 · 300,000 participants
A Real-World Registry of Chronic Wounds and Ulcers
- NCT06694181 · 300,000 participants
Safe and Explainable AI
- NCT07314697 · 300,000 participants · NA
Arrival Time Implementation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI